Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum IMV Inc IMVIF

IMV Inc. is a Canada-based company. The Company has no business operations.

Bullboard (GREY:IMVIF)

View:
Comment by Biotech010on Mar 17, 2021 8:51am

RE:Thoughts on the updates today?

It was a smart move to have Andrew on the call, the director of business development.The last question on the Q&A was good, DPX goes beyond Ovarian DLBCL etc so there is room for lots of partners. ...more  
Comment by Jthom376on Mar 17, 2021 8:48am

RE:Thoughts on the updates today?

Another quarter of waiting is my take... which translates to all of 2021. Didn't really have a lot... gave a drug a name no one will be able to say. Not bad... just similar to every other ...more  
Post by alphaseeking001on Mar 17, 2021 7:21am

Thoughts on the updates today?

Thoughts ladies and gents?  Seems positive to me but would appreciate all thoughts.  Cheers 
Comment by Jthom376on Mar 11, 2021 6:21pm

RE:RE:IMV scientific report

Thanks Q - it was above me... appreciate the nreak down. I initially got fixated on the anti inflammatory remarks noted but struggled to understand any of it. 
Comment by qwerty22on Mar 11, 2021 1:29pm

RE:IMV scientific report

It's really just science. Maybe describe it as pre-preclinical. The importance to me is in relation to the dlbcl/pd-l1 finding. What this paper talks about is the importance of immune ...more  
Comment by alexmed95on Mar 10, 2021 5:12pm

RE:RE:RE:RE:AACR abstracts in one weeks time

Nice find! Damn Nature is the most prestigious scientific journal! 
Comment by Jthom376on Mar 10, 2021 4:51pm

RE:RE:RE:AACR abstracts in one weeks time

I've looked all over AACR and don't find IMV anywhere.  Released at 4:30 today. Anyone else? 
Post by Jthom376on Mar 10, 2021 2:37pm

IMV scientific report

Anyone have any thoughts on this? Hadn't noticed it until today. https://www.nature.com/articles/s41598-021-82108-4
Comment by Jthom376on Mar 09, 2021 4:38pm

RE:RE:RE:Best takeaway

That would be a surprising development but his hopes my not be any better than my hopes... except mine cost me a lot! Would be nice! Especially combined with solid oncology. 
Comment by Biotech010on Mar 09, 2021 3:32pm

RE:RE:Best takeaway

they hope to start the Phase 1-2 of the COVID vaccine before the end of this quarter. Listen to the webcast at 25 minutes https://journey.ct.events/view/09b83699-20d3-4dc7-87a2-4a24596f4215 
Comment by qwerty22on Mar 09, 2021 3:10pm

RE:Best takeaway

That seems to be the USP they are pushing from the Ov trial so good to see that extend.  
Post by cribbonson Mar 09, 2021 9:56am

Best takeaway

Multiple years of duration for the vaccine! 
Comment by Breakthoroughon Mar 09, 2021 9:31am

RE:RE:March21 corp pres-

The important thing is that the three announcements dued to Q1 (DLBCL Trial design, ovarian biomarker, B. Trial interim data) are still announced for Q1 (see p. 28), meaning: during the three weeks ...more  
Comment by alexmed95on Mar 09, 2021 9:25am

RE:March21 corp pres-

Won't lie, not so much good news for a long time... 
Post by antigua1987on Mar 09, 2021 9:04am

March21 corp pres-

barely 3 changes fr Jan21: 1)monol OV- median duration of response now>12months, 2)dropped institutional invstr page, 3)WellsFargo analyst out.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities